Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M702169200 on June 11, 2007

J. Biol. Chem., Vol. 282, Issue 33, 23910-23918, August 17, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/33/23910    most recent
M702169200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mammoto, T.
Right arrow Articles by Sukhatme, V. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mammoto, T.
Right arrow Articles by Sukhatme, V. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Angiopoietin-1 Requires p190 RhoGAP to Protect against Vascular Leakage in Vivo*Formula

Tadanori Mammoto{ddagger}1, Samir M. Parikh{ddagger}1, Akiko Mammoto§1, Diana Gallagher{ddagger}, Barden Chan{ddagger}, Gustavo Mostoslavsky, Donald E. Ingber§, and Vikas P. Sukhatme{ddagger}2

From the {ddagger}Department of Medicine, Division of Interdisciplinary Medicine and Biotechnology and Center for Vascular Biology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, §Vascular Biology Program, Children's Hospital, Harvard Medical School, Boston, and the Department of Genetics, Harvard Medical School, Harvard Institute of Medicine, Boston, Massachusetts 02215

Angiopoietin-1 (Ang-1), a ligand of the endothelium-specific receptor Tie-2, inhibits permeability in the mature vasculature, but the mechanism remains unknown. Here we show that Ang-1 signals Rho family GTPases to organize the cytoskeleton into a junction-fortifying arrangement that enhances the permeability barrier function of the endothelium. Ang-1 phosphorylates Tie-2 and its downstream effector phosphatidylinositol 3-kinase. This induces activation of one endogenous GTPase, Rac1, and inhibition of another, RhoA. Loss of either part of this dual effect abrogates the cytoskeletal and anti-permeability actions of Ang-1, suggesting that coordinated GTPase regulation is necessary for the vessel-sealing effects of Ang-1. p190 RhoGAP, a GTPase regulatory protein, provides this coordinating function as it is phosphorylated by Ang-1 treatment, requires Rac1 activation, and is necessary for RhoA inhibition. Ang-1 prevents the cytoskeletal and pro-permeability effects of endotoxin but requires p190 RhoGAP to do so. Treatment with p190 RhoGAP small interfering RNA completely abolishes the ability of Ang-1 to rescue endotoxemia-induced pulmonary vascular leak and inflammation in mice. We conclude that Ang-1 prevents vascular permeability by regulating the endothelial cytoskeleton through coordinated and opposite effects on the Rho GTPases Rac1 and RhoA. By linking Rac1 activation and RhoA inhibition, p190 RhoGAP is critical to the protective effects of Ang-1 against endotoxin. These results provide mechanistic evidence that targeting the endothelium through Tie-2 may offer specific therapeutic strategies in life-threatening endotoxemic conditions such as sepsis and acute respiratory distress syndrome.


Received for publication, March 13, 2007 , and in revised form, May 8, 2007.

* This work was supported by seed funds from Beth Israel Deaconess Medical Center (to V. P. S.) and National Institutes of Health Grants CA45548 and CA55833 (to D. E. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Data A–F, Methods, and Figs. 1–3.

1 These authors contributed equally to this work.

2 To whom correspondence may be addressed: Dept. of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave., RW 563, Boston, MA 02215. Tel.: 617-667-2105; Fax: 617-667-7851; E-mail: vsukhatm{at}bidmc.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H. T. Yuan, E. V. Khankin, S. A. Karumanchi, and S. M. Parikh
Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
Mol. Cell. Biol., April 15, 2009; 29(8): 2011 - 2022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Shimizu, A. Mammoto, J. E. Italiano Jr., E. Pravda, A. C. Dudley, D. E. Ingber, and M. Klagsbrun
ABL2/ARG Tyrosine Kinase Mediates SEMA3F-induced RhoA Inactivation and Cytoskeleton Collapse in Human Glioma Cells
J. Biol. Chem., October 3, 2008; 283(40): 27230 - 27238.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M van der Heijden, G P van Nieuw Amerongen, P Koolwijk, V W M van Hinsbergh, and A B J Groeneveld
Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients
Thorax, October 1, 2008; 63(10): 903 - 909.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. N. Gavrilovskaya, E. E. Gorbunova, N. A. Mackow, and E. R. Mackow
Hantaviruses Direct Endothelial Cell Permeability by Sensitizing Cells to the Vascular Permeability Factor VEGF, while Angiopoietin 1 and Sphingosine 1-Phosphate Inhibit Hantavirus-Directed Permeability
J. Virol., June 15, 2008; 82(12): 5797 - 5806.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Guegan, F. Tatin, T. Leste-Lasserre, G. Drutel, E. Genot, and V. Moreau
p190B RhoGAP regulates endothelial-cell-associated proteolysis through MT1-MMP and MMP2
J. Cell Sci., June 15, 2008; 121(12): 2054 - 2061.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement